Delhi govt introduces landmark reform to fast-track green category
Delhi's Environment and Industries Minister Manjinder Singh Sirsa, while announcing the decision, described it as a 'historic reset' in the way Delhi supports enterprise. He emphasized that this reform had been a long-standing demand from the business community and was finally addressed through the leadership of Chief Minister Rekha Gupta and Lieutenant Governor Vinai Kumar Saxena.
Sirsa remarked that what hadn't been accomplished in five decades has now been delivered under the double-engine government, adding that Delhi is now 'open for responsible business.' He further stated that the government is moving away from a system of unnecessary licenses and outdated approvals, replacing it with a model that is pro-growth, pro-people, and purpose-driven.
The reform will directly impact over 65 types of industries categorized as green, which are considered non-polluting and relatively safe for the environment. These include sectors like apparel manufacturing (excluding dyeing or bleaching processes), aluminium and PVC product units, ayurvedic medicine manufacturing without boilers, cold storage operations, wooden and steel furniture production, confectionery units using electric ovens, optical goods manufacturing, toy assembly, soap and detergent units, battery container production, and packaging and cardboard manufacturers, among others.
All of these sectors, many of which are dominated by micro, small, and medium enterprises (MSMEs), were previously subjected to long and often frustrating bureaucratic delays. Now, under the new policy, if a CTO application is not addressed within 20 days, it will be automatically treated as approved, eliminating the need for further follow-ups or additional paperwork.
The Delhi Government believes this reform will be a game-changer for small businesses that have historically struggled under the weight of regulatory red tape. Most of the green category industries are run by small and medium-scale entrepreneurs who can now operate with greater freedom and certainty under a trust-based, time-bound clearance system. Minister Sirsa noted that this move will help these enterprises shift their focus from chasing approvals to scaling their operations and contributing more effectively to the local economy.
This decision is also closely aligned with the broader national vision of Viksit Bharat – Viksit Delhi and reflects the capital's commitment to responsive and modern governance. It forms a key part of Delhi's ongoing Single Window Clearance initiative, which aims to eliminate redundant approvals and create a streamlined, paperless, and transparent framework for industrial operations. By reducing bureaucratic friction and empowering entrepreneurs, the Delhi Government hopes to foster a more dynamic, business-friendly environment that promotes both sustainable development and economic growth.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
News18
17 hours ago
- News18
'No Fear, No Pressure': Govt Says India In A Strong Bargaining Position With Trump On Trade Tariffs
Last Updated: Commerce minister Piyush Goyal outlined the two pillars of the negotiations: one, Viksit Bharat, and two, Atmanirbhar No fear, no pressure—the government has made it clear that when it comes to dealing with the United States on trade tariffs, this will be the mantra. Commerce minister Piyush Goyal outlined the two pillars of the negotiations: one, Viksit Bharat, and two, Atmanirbhar. The US negotiating team is expected to arrive for a scheduled meeting on August 25. While New Delhi aims for a favourable deal with one of its biggest trade partners, it has made clear to American negotiators that India does not make deals under pressure or deadlines. Several reasons support the government's confidence, as highlighted by the commerce minister. India is a trillion-dollar growing economy and has risen to be the world's fifth-largest. This growth has captured the attention of global economies and economic experts, giving India a strong bargaining position. Additionally, the recently concluded trade agreement with the United Kingdom sends a strong message to the US and the world: India will negotiate deals that align with its national interest. Even regarding oil, India refuses to succumb to American pressure. Despite Trump imposing a 10% penalty for buying Russian oil, India has made it clear that it will buy from the supplier offering the best rate to benefit consumers. The ministry of external affairs echoed this stance, stating, 'In securing our energy needs, we are guided by what is on offer in the markets and by the prevailing global circumstances." According to government sources, Trump has also offered low tariffs to Pakistan and Bangladesh, but this does not concern India, as their trade is negligible. India remains powerful, strong, and resilient. Unlike other heads of state who have sought to persuade the American president to reduce tariffs, the Indian side has refused to compromise. In upcoming meetings with American negotiators, Indian representatives will firmly state their positions: no concessions in the agro sector, no easy access for American products to Indian markets, no GM foods, and no harm to the labour-intensive sector. The government believes American consumers could suffer from these stances since Indian products have flooded the market. Moreover, Tim Cook, the Apple CEO, has publicly praised Indian manpower for its unmatched excellence. With this high stance, the commerce minister has made it clear that India has nothing to worry about. view comments Disclaimer: Comments reflect users' views, not News18's. Please keep discussions respectful and constructive. Abusive, defamatory, or illegal comments will be removed. News18 may disable any comment at its discretion. By posting, you agree to our Terms of Use and Privacy Policy.
Hans India
2 days ago
- Hans India
Toyota Kirloskar Motor inaugurates New City Office in Chhatrapati Sambhaji Nagar
Toyota Kirloskar Motor (TKM) today announced the inauguration of its new city office in Chhatrapati Sambhaji Nagar (CSN), Maharashtra — a key milestone towards strengthening its presence in the State of Maharashtra and reaffirming its commitment to contributing India's automotive industry. This development follows the Memorandum of Understanding (MoU) signed between TKM and the Government of Maharashtra in July 2024, aimed at facilitating the establishment of a Greenfield Manufacturing Facility in the region. The new office will serve as a critical hub for advancing TKM's regional operations and reinforcing its long-term commitment to industrial development with focus on sustainability, creation of skilled manpower and jobs, and giving back to the society across Maharashtra. The new office located at ABC EAST Beside Prozone Mall Chikalthana spanning 7000 sq. ft. was inaugurated by Masakazu Yoshimura, Chairman, MD & CEO, TKM, Swapnesh Maru, Deputy Managing Director Corporate Planning, Green Field Project. This newly established office reinforces TKM's commitment to strengthening its presence in Maharashtra, contributing to the region's emergence as a manufacturing hub, and deepening engagement with key stakeholders—including local authorities, industry bodies. Speaking at the inauguration, Mr. Swapnesh Maru, Deputy Managing Director Corporate Planning, Green Field Project, TKM said, 'The inauguration of our new office in Chhatrapati Sambhaji Nagar will enable us with a more localised approach by deepening our market engagement and stakeholder connect. Looking ahead, we remain committed to bringing in world-class manufacturing capabilities to the region—unlocking Marathwada's potential by creating employment, nurturing skilled talent, and driving inclusive, sustainable growth. With strong government support, we are confident that our presence will serve as a catalyst for regional transformation and aligns with our vision of contributing to India's industrial development and the national aspiration of Viksit Bharat @2047.' Guided by the philosophy of 'Grow India – Grow with India', the inauguration of the Office in Chhatrapati Sambhaji Nagar is a reaffirmation of Toyota's deep-rooted belief in India's growth potential. With a strong legacy behind it and a future anchored in innovation, sustainability, and local empowerment, TKM remains steadfast in its commitment to nurturing a robust mobility ecosystem that supports both regional aspirations and national development goals. With the MoU progressing as planned, TKM is actively workings towards rolling out key initiatives to strengthen the local ecosystem. These efforts include the launch of industry-relevant skill development programs and targeted support to educational institutions, encompassing infrastructure upgrades and access to essential learning resources—further reinforcing TKM's commitment to inclusive and sustainable growth by contributing towards the creation of a skilled worldclass talent pool.
The Hindu
2 days ago
- The Hindu
‘Tariffs on Indian imports will strain U.S. healthcare budgets'
U.S. President Donald Trump's decision to impose 25% tariffs on goods imported from India may interrupt the smooth trade flow, inflate U.S. drug costs, stall treatments, and put even greater pressure on American healthcare budgets, cautioned pharma experts in India. Back home, profits of Indian pharmaceutical firms may decline, and research and development may stagnate, slowing down innovation and stalling new drug clearances, they added. 'India isn't just a key supplier of generic medicines to the U.S. but also part of the backbone of affordable global healthcare. This latest move is a wake-up call and India must double down on securing free trade agreements with other major economies,' said Sanjaya Mariwala, executive chairman and MD of OmniActive Health Technologies. 'These aren't just about market access; they're about securing India's place in the world economy and advancing the vision of a Viksit Bharat. The 25% penalty and fine are a serious blow to India's exports, especially when the U.S. has been our biggest trading partner for years. Pharma and electronics are taking the biggest hit. Beyond monetary, this move adds a layer of uncertainty to an already shaky global trade environment,' he added. Stating that India has long been a cornerstone of the global pharmaceutical supply chain, especially in generics, supplying about 47% of all generic prescriptions in the U.S. in 2022, Bhavin Mukund, vice-chairman, Pharmexcil said, 'While we understand the evolving trade policies of our global partners, the proposed 25% tariff on Indian pharmaceutical imports effective August 1 raises concerns about rising costs and potential disruptions in medicine access for U.S. patients. Such policy shifts could inadvertently affect public health outcomes. We remain committed to open and constructive dialogue, and we emphasise the strategic importance of India–U.S. pharmaceutical trade in ensuring affordable, high quality healthcare globally.' The top five medical device exports to the U.S. include endoscopes, orthopaedic implants, MRI equipment, urinary catheters and electrocardiographs. 'If duties by the U.S. on Indian medical device are 15-20% lower than its tariffs on China, exports could rise if manufacturers find it feasible to absorb FDA approval costs and deeming these export costs sustainable,'' said Rajiv Nath, forum coordinator at Association of Indian Medical Device Industry (AiMeD). He further noted that U.S. buyers were looking to diversify their supply chains away from China, and India represented a viable alternative, assuming it can ensure quality, competitive pricing, and agility, while also adhering to environmental, social, and corporate responsibility standards. He, however, cautioned that India could face a loss of competitiveness to Indonesia and Vietnam, especially in rubber-based products due to their advantageous tariffs and suggested that India needed to enhance its competitiveness in areas beyond pricing. Meanwhile industry experts said that they awaited greater clarity and also confirmation of duties on Chinese goods. 'Should duties on Chinese medical devices return to levels exceeding 50% post-August, and should duties on Indian devices by the USA be established at 25%, export prospects to the U.S. would likely remain favourable in comparison to China. The ultimate impact of duties on the Indian medical device sector is dependent on relative competitiveness. A duty differential of 15-20% between Chinese and Indian products would favour Indian exports to the U.S., potentially incentivising the establishment of production lines within the US,' said Mr. Nath.
